Used primarily as an antipsychotic and antiemetic agent, this compound is effective in managing symptoms of schizophrenia and other psychiatric disorders, particularly those involving negative symptoms such as social withdrawal and emotional flatness. It acts as a selective dopamine D2 and D3 receptor antagonist, which contributes to its atypical antipsychotic profile with a lower incidence of extrapyramidal side effects compared to conventional antipsychotics. Additionally, it is employed in the treatment of gastrointestinal disorders due to its ability to modulate dopamine receptors in the gut, helping alleviate nausea and vomiting. Its enantiomeric specificity enhances receptor binding affinity, making the (S) enantiomer particularly active in therapeutic applications.